Home Health Care Regeneron’s cholesterol-lowering drug approved by FDA

Regeneron’s cholesterol-lowering drug approved by FDA

SHARE

The Food and Drug Administration approves the use of Praluent, developed by Regeneron Pharmaceuticals in Westchester and its French collaborator Sanofi.

This content is for Westfair Online members only. Please to view this content. Become a member by Registering Here.
Print Friendly, PDF & Email